[1] |
ZHU Yurong, ZHANG Dan, HE Yaxing, LI Jingjing, HUANG Jing, LI Ting, LIU Peng, LIU Ronghua.
Classification and epidemiology characteristics of Klebsiella pneumoniae isolated from clinic
[J]. Laboratory Medicine, 2023, 38(5): 435-440.
|
[2] |
WANG Jiawei, ZHU Weinan, CHEN Yingying, JI Ping, WANG Ying.
Clinical characteristics,molecular typing and drug resistance genes of carbapenem-resistant Klebsiella pneumoniae isolated from blood culturing
[J]. Laboratory Medicine, 2023, 38(4): 362-367.
|
[3] |
REN Yanfei, ZHANG Min, YANG Tao, LI Rongkai, LIANG Xin.
Analysis of pathogenic epidemiology of patients with lower respiratory tract infection in respiratory intensive care unit
[J]. Laboratory Medicine, 2023, 38(2): 157-162.
|
[4] |
DENG Chen, DAI Jiaze, QIU Lihong, SHEN Weiting, CAI Mufa, LUO Wenying.
Molecular epidemic characteristics of hypervirulent Klebsiella pneumoniae in Zhanjiang
[J]. Laboratory Medicine, 2023, 38(11): 1026-1031.
|
[5] |
WANG Su, DING Li, JIANG Wenrong, MIAO Yingxin, ZHANG Yanmei, ZHAO Hu.
Research progress on drug resistance and treatment strategies of hypervirulent Klebsiella pneumoniae
[J]. Laboratory Medicine, 2023, 38(1): 81-86.
|
[6] |
WANG Shiqi, LI Henan, LIU Jingbo, WANG Zhanwei, WANG Zhiren, CHI Dali, WANG Hui.
Application evaluation of loop-mediated isothermal amplification in determining Clostridioides difficile in fecal samples
[J]. Laboratory Medicine, 2022, 37(9): 860-863.
|
[7] |
HUANG Yun, LI Congrong.
Research progress on hypervirulent Klebsiella pneumonia
[J]. Laboratory Medicine, 2021, 36(11): 1181-1185.
|
[8] |
ZHOU Yanxia, JIN Dongfang.
Inhibition and mechanism of tannic acid on biofilm formation in Klebsiella pneumoniae
[J]. Laboratory Medicine, 2021, 36(10): 1070-1073.
|
[9] |
WANG Junjie, YAO Zonghui, MA Bing, LI Yi, YAN Wenjuan, WANG Shanmei, MA Qiong, YUAN Youhua.
Risk factors and prognosis of bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
[J]. Laboratory Medicine, 2020, 35(3): 195-199.
|
[10] |
NIU Jing, QUAN Wenqiang, LI Dong.
Establishment and application of loop-mediated isothermal amplification for EGFR gene L858R mutation determination in non-small cell lung cancer patients
[J]. Laboratory Medicine, 2020, 35(3): 273-277.
|
[11] |
ZHOU Hongwei, HU Yanyan, ZHANG Rong.
Determination methods for carbapenem-resistant Enterobacteriaceae
[J]. Laboratory Medicine, 2020, 35(10): 971-973.
|
[12] |
HE Lihua, NI Lijun, YANG Simin, YU Xiaoyu, ZHOU Aiping, HU Liang, GUO Jian, WU Wenjuan.
Clinical application of RT-PCR for Klebsiella pneumoniae producing KPC carbapenemase
[J]. Laboratory Medicine, 2020, 35(10): 983-987.
|
[13] |
CHEN Tao, XU Ye, DONG Guofeng, ZHOU Cui, XU Wenya, ZHOU Tieli.
In vitro antibacterial activity of ceftazidime/avibactam alone and in combination with fosfomycin against carbapenem-resistant Gram-negative bacilli
[J]. Laboratory Medicine, 2020, 35(10): 988-993.
|
[14] |
WEN Weihong, LIANG Yingjian, MA Furong, LI Yuzhen, XU Lingqing.
Carbapenemase detection and multilocus sequence typing analysis of carbapenem-resistant Enterobacteriaceae
[J]. Laboratory Medicine, 2019, 34(7): 577-582.
|
[15] |
ZHANG Baohua, YU Guixiang, JIANG Yan, PAN Hong, JIANG Xiangning.
Performance evaluation of GN13 and NM38 to determine the drug susceptibility of carbapenems against Klebsiella pneumoniae
[J]. Laboratory Medicine, 2019, 34(3): 263-266.
|